Abstract
Mutations in the dysferlin (DYSF) gene are associated with limb girdle muscular dystrophy type 2B and Miyoshi myopathy. In this study, we report the identification and characterization of a novel dysferlin transcript that we named DYSF_v1 (GenBank accession: DQ267935). This transcript differs from the currently known dysferlin transcript (GenBank accession: AF075575) in the sequence of the entire first exon which spans 232 bases. This unique first exon is derived from intron 1 of DYSF, and has an immediate upstream 5′ untranslated region containing CpG islands and sequences consistent with transcription factor binding sites. Exon 1 of DYSF_v1 shares 85% sequence homology and has similar genomic organization with the first exon of mouse dysferlin. Northern blot analysis showed that the DYSF_v1 transcript spans 7.5 kb and is expressed in human skeletal muscle, heart, placenta, brain, spleen, kidney, intestine, and lung tissues. DYSF_v1 retains phylogenic conservancy and shows similar expression pattern as the currently known human dysferlin.
Similar content being viewed by others
References
Anderson LV, Davison K, Moss JA, Young C, Cullen MJ, Walsh J, Johnson MA, Bashir R, Britton S, Keers S, Argov Z, Mahjneh I, Fougerousse F, Beckmann J, Bushby K (1999) Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet 8:855–861
Aoki M, Liu J, Richard I, Bashir R, Britton S, Keers S, Oeltjen J, Brown HE, Marchand S, Bourg N, Beley C, McKenna-Yasek D, Arahata K, Bohlega S, Cupler E, Illa I, Majneh I, Barohn RJ, Urtizberea JA, Fardeau M, Amato A, Angelini C, Bushby K, Beckmann JS, Brown RH Jr (2001) Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathy. Neurology 57:271–278
Ayoubi TA, Van De Ven WJ (1996) Regulation of gene expression by alternative promoters. FASEB J 10:453–460
Bansal D, Campbell KP (2004) Dysferlin and the plasma membrane repair in muscular dystrophy. Trends Cell Biol 14:206–213
Bashir R, Britton S, Strachan T, Keers S, Vafiadaki E, Lako M, Richard I, Marchand S, Bourg N, Argov Z, Sadeh M, Mahjneh I, Marconi G, Passos-Bueno MR, Moreira Ede S, Zatz M, Beckmann JS, Bushby K (1998) A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet 20:37–42
Britton S, Freeman F, Vafiadaki E, Keers S, Harrison R, Bushby K, Bashir R (2000) The third human FER-1-like protein is highly similar to dysferlin. Genomics 68:313–321
Corpet F (1988) Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res 16(22):10881–10890
Cox GF, Kunkel LM (1997) Dystrophies and heart disease. Curr Opin Cardiol 12:329–343
Davis DB, Delmonte AJ, Ly CT, McNally EM (2000) Myoferlin, a candidate gene and potential modifier of muscular dystrophy. Hum Mol Genet 9:217–226
Davis DB, Doherty KR, Delmonte AJ, McNally EM (2002) Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains. J Biol Chem 277:22883–22888
Foxton RM, Laval SH, Bushby KMD (2004) Characterization of the dysferlin skeletal muscle promoter. Eur J Hum Genet 12:127–131
Hebsgaard SM, Korning PG, Tolstrup N, Engelbrecht J, Rouze P, Brunak S (1996) Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information. Nucleic Acids Res 24(17):3439–3452
Ho MF, Post CM, Donahue LR, Lidov HG, Bronson RT, Goolsby H, Watskin SC, Cox GA, Brown RH Jr (2004) Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency. Hum Mol Genet 13:1999–2010
Lennon NJ, Kho A, Bacskai BJ, Perlmutter SL, Hyman BT, Brown RH Jr (2003) Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing. J Biol Chem 278:50466–50473
Letunic I, Copley RR, Schmidt S, Ciccarelli FD, Doerks T, Schultz J, Ponting CP, Bork P (2004) SMART 4.0: towards genomic data integration. Nucleic Acids Res 32:142–144
Liu J, Aoki M, Illa I, Wu C, Fardeau M, Angelini C, Serrano C, Urtizberea JA, Hentati F, Hamida MB, Bohlega S, Culper EJ, Amato AA, Bossie K, Oeltjen J, Nejaoui, McKenna-Yasek D, Hosler BA, Schurr E, Arahata K, de Jong PJ, Brown RH Jr (1998) Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 20:31–36
Loots G, Ovcharenko I, Pachter L, Dubchak I, Rubin E (2002) rVISTA for comparative sequence-based discovery of functional transcription factor binding sites. Genome Res 12:832–839
Matsuda C, Aoki M, Hayashi YK, Ho MF, Arahata K, Brown RH Jr (1999) Dysferlin is a surface membrane-associated protein that is absent in Miyoshi myopathy. Neurology 53:1119–1122
Matsuda C, Hayashi YK, Ogawa M, Aoki M, Murayama K, Nishino I, Nonaka I, Arahata K, Brown RH Jr (2001) The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum Mol Genet 10:1761–1766
Salani S, Lucchiari S, Fortunato F, Crimi M, Corti S, Locatelli F, Bossolasco P, Bresolin N, Comi GP (2004) Developmental and tissue-specific regulation of a novel dysferlin isoform. Muscle Nerve 30:366–374
Scapagnini G, Agata VD, Calabrese V, Pascale A, Colombrita C, Alkon D, Cavallaro S (2002) Gene expression profiles of heme oxygenase isoforms in the rat brain. Brain Res 954:51–59
Schultz J, Milpetz F, Bork P, Ponting CP (1998) SMART, a simple modular architecture research tool: identification of signalling domains. Proc Natl Acad Sci USA 95:5857–5864
Schultz J, Copley RR, Doerks T, Ponting CP, Bork P (2000) SMART: a web-based tool for the study of genetically mobile domains. Nucleic Acids Res 28:231–234
Shapiro MB, Senapathy (1987) RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 15:7155–7174
Shine J, Dalgarno L (1975) Determinant of cistron specificity in bacterial ribosomes. Nature 254(5495):34–38
Strachan T, Read AP (1999) Human gene expression. In: Human molecular genetics, 2nd edn. Wiley and Sons (Asia) Pvt Ltd, pp 139–168
Suzuki T, Higgins PJ, Crawford DR (2000) Control selection for RNA quantitation. BioTechniques 29:332–333
Takai D, Jones PA (2002) Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA 99:3740–3745
Weiler T, Bashir R, Anderson LV, Davidson K, Davison K, Moss JA, Britton S, Nylen E, Keers S, Vafiadaki E, Grennberg CR, Bushby CR, Wrogemann K (1999) Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s). Hum Mol Genet 8(5):871–877
Acknowledgements
We wish to thank Dr Mac MF Ho for useful advice. We also thank Dr Katsutoshi Yuasa and Lim Chui Chin for their assistance in Northern blot analysis. This work was supported by grant funding NMRC/0607/2001 from the National Medical Research Council, Singapore.
Author information
Authors and Affiliations
Corresponding author
Additional information
GenBank accession number of dysferlin_v1 is DQ267935
Rights and permissions
About this article
Cite this article
Pramono, Z.A.D., Lai, P.S., Tan, C.L. et al. Identification and characterization of a novel human dysferlin transcript: dysferlin_v1. Hum Genet 120, 410–419 (2006). https://doi.org/10.1007/s00439-006-0230-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-006-0230-1